SereNeuro Therapeutics - Deciphering the functional heterogeneity of human pain perception and developing therapies for non-opioid pain relief

Transforming Pain Relief

Non-opioid therapies for chronic and neuropathic pain

Powerful Relief. No Addiction. We’re breaking the cycle of pain and the opioid crisis.

About

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

SereNeuro Therapeutics is a preclinical biotechnology company developing non-opioid pain therapies with a novel approach to chronic pain management and joint tissue preservation. Our lead candidate SN101 is a first-in-class induced pluripotent stem cell (iPSC)-derived therapy.

SN101 uses mature iPSC-derived peripheral pain-sensing neurons (nociceptors) to treat chronic osteoarthritis joint pain. Our approach challenges the traditional logic of pain management.